Medical Device | June 22, 2026
BPL Medical honours strategic partners with Pinnacle Awards 2026
The company hosted Symbiosis 2026 at its 2-acre manufacturing facility in Bengaluru, inaugurated in 2024
The company hosted Symbiosis 2026 at its 2-acre manufacturing facility in Bengaluru, inaugurated in 2024
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
Acquisition of Mumbai-based pharmaceutical, nutraceutical and cosmeceutical company expected to be completed by July 2026
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
The new facility will produce precision extruded medical tubing used in minimally invasive medical devices
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
The collaboration is focused on overcoming a major limitation in existing cancer drugs
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
Upon completion of the merger, Assertio will become a wholly owned subsidiary of Zydus Lifesciences and will be delisted from the Nasdaq
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
